First Omalizumab Biosimilar Approved

(MedPage Today) — The FDA approved omalizumab-igec (Omlyclo) as the first biosimilar for omalizumab (Xolair) and the first for any respiratory condition in the U.S., drugmaker Celltrion announced Monday.
The anti-immunoglobulin E (IgE) antibody…